Biologics for Stricturing Crohn's Diseases
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.
| Condition(s) | The Efficacy of Biologics for Stricturing Crohn's Diseases |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases. |
| Who can participate | Inclusion Criteria: * patients with stricturing Crohn's diseases * no surgical indication * patients with asymptomatic penetrating diseases * written consent acquired Exclusion Criteria: * patients with surgical indication * patients with symptomatic penetrating diseases * contraindication of biologics * anticipating other trial |
| Ages | 16 Years to 65 Years |
| Sex | All |
| Lead sponsor | Jinling Hospital, China |
| Locations | Nanjing, Jiangsu, China |
| Start date | 2021-01-01 |
| NCT ID | NCT05645055 |
| Official listing | https://clinicaltrials.gov/study/NCT05645055 |